Eisai Ltd., of Hatfield, UK, part of Eisai Co. Ltd., said data from a large extension study of Fycompa (perampanel), published online in Epilepsia, showed the epilepsy treatment reduced seizure frequency over sustained periods of up to two years of treatment.